BMF meeting covers AI in biomanufacturing
The use of artificial intelligence in the life sciences and in biomanufacturing was the topic of the NCLifeSci Biotech Manufacturers Forum quarterly meeting held Nov. 14 at the NC Biotechnology Center.
Representatives from Kymanox, Human Ready and Metalytics shared insights into how the FDA is treating AI, how companies can improve efficiency with generative analytics and data storytelling and how AI can be used to model the activity in a bioreactor.
Bill Monteith, who succeeds John Wagner as BMF program director, introduced himself and gave an overview of his 42-year career in pharmaceutical manufacturing. NCLifeSci President Laura Gunter provided an update on state and federal issues of interest.
- The NC General Assembly has allocated $500 million over the next two years to support innovation and technology development in the state.
- The state also provided some funding for community college and university faculty raises.
- There was some adjustment to the franchise tax, which will benefit some smaller companies.
- The legislature is considering a policy on PFAS, a chemical found in some plastics and coatings.
After the update, Gunter recognized and thanked Brenda Summers, Ed.D., who will be retiring Nov. 30 from her role as NCLifeSci’s director of workforce programs.
“She has been a friend, a colleague, a mentor, adviser, you name it and she's done it,” Gunter said. “She's in a lot of ways the heart and soul of the organization.”
The meeting program consisted of three presentations focused on aspects of using AI in biomanufacturing. The presenters were
- Izi Bruker, Ph.D., a fellow in clinical, medical and regulatory affairs at Kymanox;
- Teresa Monteiro, head of business development in North America for Human Ready; and
- Sam Yenne, chief operating officer of Metalytics.